Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-10-26-Speech-3-232"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2005-10-26"^^xsd:date2
dcterms:Is Part Of	lp_eu:Council Question Time2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20051026.18.3-232"2
lpv:hasSubsequent	lp_eu:2005-10-26-Speech-3-2332
lpv:speaker	lp:Manuel dos Santos2
lpv:spokenAs	vice-president; European Parliament (2005-04-12--2007-01-15)3 substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2004-09-15--2009-07-13)3 substitute; ITRE (2004-07-21--2007-01-14)3 vice-president; Parliament's Bureau (2005-04-12--2007-01-15)3 member; ECON (2004-07-21--2007-01-14)3 member; PES (2004-07-20--2009-07-13)3 unknown; Partido Socialista (2004-07-20--2009-07-13)3 member; Delegation for relations with the Maghreb countries and the Arab Maghreb Union (including Libya) (2004-10-28--2007-03-13)3
lpv:translated text	"Question No 7 by Catherine Stihler () 4.9 million people were infected with HIV in 2004, more than in any previous year. As 75% of young people infected are women and girls, the increasing vulnerability of women is underlined along with the inherent need to expand current prevention options, particularly for women. The European and Developing Countries Clinical Trials Partnership (EDCTP) was set up in February 2004, with one third of its budget to be funded by Member States (plus one third from the Commission, and one third from the private sector). In the light of the rise in HIV infection rates and the creation of the EDCTP, can the Council provide information on what funding Member States have provided to the EDCTP, and as a result, which microbicide clinical trials are currently being funded by the EDCTP?"@en1
lpv:unclassifiedMetadata	"President. –"1 "Subject: Microbicide clinical trials"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph